747 related articles for article (PubMed ID: 24022745)
1. Synthesis, molecular structure, computational study and in vitro anticancer activity of dinuclear thiolato-bridged pentamethylcyclopentadienyl Rh(III) and Ir(III) complexes.
Gupta G; Garci A; Murray BS; Dyson PJ; Fabre G; Trouillas P; Giannini F; Furrer J; Süss-Fink G; Therrien B
Dalton Trans; 2013 Nov; 42(43):15457-63. PubMed ID: 24022745
[TBL] [Abstract][Full Text] [Related]
2. Biological studies of chalcogenolato-bridged dinuclear half-sandwich complexes.
Johnpeter JP; Gupta G; Kumar JM; Srinivas G; Nagesh N; Therrien B
Inorg Chem; 2013 Dec; 52(23):13663-73. PubMed ID: 24245963
[TBL] [Abstract][Full Text] [Related]
3. Antitumor pentamethylcyclopentadienyl rhodium complexes of maltol and allomaltol: synthesis, solution speciation and bioactivity.
Dömötör O; Aicher S; Schmidlehner M; Novak MS; Roller A; Jakupec MA; Kandioller W; Hartinger CG; Keppler BK; Enyedy ÉA
J Inorg Biochem; 2014 May; 134():57-65. PubMed ID: 24556426
[TBL] [Abstract][Full Text] [Related]
4. Anticancer potential of (pentamethylcyclopentadienyl)chloridoiridium(III) complexes bearing κP and κP,κS-coordinated Ph2 PCH2 CH2 CH2 S(O)x Ph (x=0-2) ligands.
Ludwig G; Ranđelović I; Maksimović-Ivanić D; Mijatović S; Bulatović MZ; Miljković D; Korb M; Lang H; Steinborn D; Kaluđerović GN
ChemMedChem; 2014 Jul; 9(7):1586-93. PubMed ID: 24470190
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of new polynuclear organometallic Ru(II), Rh(III) and Ir(III) pyridyl ester complexes as in vitro antiparasitic and antitumor agents.
Chellan P; Land KM; Shokar A; Au A; An SH; Taylor D; Smith PJ; Riedel T; Dyson PJ; Chibale K; Smith GS
Dalton Trans; 2014 Jan; 43(2):513-26. PubMed ID: 24121555
[TBL] [Abstract][Full Text] [Related]
6. Exploiting natural products to build metalla-assemblies: the anticancer activity of embelin-derived Rh(III) and Ir(III) metalla-rectangles.
Gupta G; Kumar JM; Garci A; Nagesh N; Therrien B
Molecules; 2014 May; 19(5):6031-46. PubMed ID: 24824137
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, structural characterization, and ligand replacement reactions of gem-dithiolato-bridged rhodium and iridium complexes.
Rivas AB; Gascón JM; Lahoz FJ; Balana AI; Pardey AJ; Oro LA; Pérez-Torrente JJ
Inorg Chem; 2008 Jul; 47(13):6090-104. PubMed ID: 18507456
[TBL] [Abstract][Full Text] [Related]
8. Organometallic rhodium(III) and iridium(III) cyclopentadienyl complexes with curcumin and bisdemethoxycurcumin co-ligands.
Pettinari R; Marchetti F; Pettinari C; Condello F; Petrini A; Scopelliti R; Riedel T; Dyson PJ
Dalton Trans; 2015 Dec; 44(47):20523-31. PubMed ID: 26548708
[TBL] [Abstract][Full Text] [Related]
9. DNA binding and anti-cancer activity of redox-active heteroleptic piano-stool Ru(II), Rh(III), and Ir(III) complexes containing 4-(2-methoxypyridyl)phenyldipyrromethene.
Gupta RK; Pandey R; Sharma G; Prasad R; Koch B; Srikrishna S; Li PZ; Xu Q; Pandey DS
Inorg Chem; 2013 Apr; 52(7):3687-98. PubMed ID: 23477351
[TBL] [Abstract][Full Text] [Related]
10. Crystal structures and DFT calculations of new chlorido-dimethylsulfoxide-M(III) (M = Ir, Ru, Rh) complexes with the N-pyrazolyl pyrimidine donor ligand: kinetic vs. thermodynamic isomers.
Cánaves MM; Cabra MI; Bauzá A; Cañellas P; Sánchez K; Orvay F; García-Raso A; Fiol JJ; Terrón A; Barceló-Oliver M; Ballester P; Mata I; Molins E; Hussain F; Frontera A
Dalton Trans; 2014 May; 43(17):6353-64. PubMed ID: 24599509
[TBL] [Abstract][Full Text] [Related]
11. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
[TBL] [Abstract][Full Text] [Related]
12. On the antitumor properties of novel cyclometalated benzimidazole Ru(II), Ir(III) and Rh(III) complexes.
Yellol GS; Donaire A; Yellol JG; Vasylyeva V; Janiak C; Ruiz J
Chem Commun (Camb); 2013 Dec; 49(98):11533-5. PubMed ID: 24177492
[TBL] [Abstract][Full Text] [Related]
13. Comparative solution equilibrium studies of antitumor ruthenium(η
Dömötör O; Pape VFS; May NV; Szakács G; Enyedy ÉA
Dalton Trans; 2017 Mar; 46(13):4382-4396. PubMed ID: 28287667
[TBL] [Abstract][Full Text] [Related]
14. Redox chemistry, acid reactivity, and hydrogenation reactions of two-electron mixed valence diiridium and dirhodium complexes.
Teets TS; Cook TR; McCarthy BD; Nocera DG
Inorg Chem; 2011 Jun; 50(11):5223-33. PubMed ID: 21557564
[TBL] [Abstract][Full Text] [Related]
15. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro antitumor activity of novel iridium(III) complexes with enantiopure C2-symmetrical vicinal diamine ligands.
Yang Q; Chang J; Song J; Qian MT; Yu JM; Sun X
Bioorg Med Chem Lett; 2013 Aug; 23(16):4602-7. PubMed ID: 23849808
[TBL] [Abstract][Full Text] [Related]
17. An approach to bimetallic catalysts by ligand design.
López-Valbuena JM; Escudero-Adan EC; Benet-Buchholz J; Freixa Z; van Leeuwen PW
Dalton Trans; 2010 Sep; 39(36):8560-74. PubMed ID: 20697645
[TBL] [Abstract][Full Text] [Related]
18. Similarities and differences in d
Gilewska A; Barszcz B; Masternak J; Kazimierczuk K; Sitkowski J; Wietrzyk J; Turlej E
J Biol Inorg Chem; 2019 Jun; 24(4):591-606. PubMed ID: 31115765
[TBL] [Abstract][Full Text] [Related]
19. Regulating the anticancer properties of organometallic dendrimers using pyridylferrocene entities: synthesis, cytotoxicity and DNA binding studies.
Govender P; Riedel T; Dyson PJ; Smith GS
Dalton Trans; 2016 Jun; 45(23):9529-39. PubMed ID: 27193373
[TBL] [Abstract][Full Text] [Related]
20. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
